Carl E Allen, MD, PhD
Baylor College of Medicine
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Carl E Allen, MD, PhD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 10:19 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT04079179 · Cobimetinib in Refractory Langerhans Cell Histiocytosis (LCH), and Other Histiocytic DisordersCarl Allen · recruiting · Langerhan's Cell Histiocytosis, Juvenile Xanthogranuloma, Erdheim-Chester Disease · study chair
- Ph2NCT01858922 · Chemotherapy With or Without Radiation, Low and Intermediate Risk Hodgkins Lymphoma, TXCH-HD-12ABaylor College of Medicine · completed · Hodgkin Disease · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 10:19 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 1 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.